Spencer Stoddard
Psychiatric/Mental Health · Lincoln, NENPI 1417645193
Payments from drug & device makers
Across 149 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$572
- Otsuka America Pharmaceutical, Inc.$377
- Axsome Therapeutics, Inc.$371
- E.r. Squibb & Sons, L.L.C.$284
- Jazz Pharmaceuticals Inc.$251
- Alkermes, Inc.$195
- plus $561 from 10 others
What the payments were for
- Food & beverage$2,610100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $572 |
| Otsuka America Pharmaceutical, Inc. | 19 | $377 |
| Axsome Therapeutics, Inc. | 21 | $371 |
| E.r. Squibb & Sons, L.L.C. | 21 | $284 |
| Jazz Pharmaceuticals Inc. | 12 | $251 |
| Alkermes, Inc. | 21 | $195 |
| Supernus Pharmaceuticals, Inc. | 3 | $188 |
| Johnson & Johnson | 8 | $136 |
| Corium, LLC | 9 | $104 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $22 |
| Harmony Biosciences LLC | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,610 in reported general payments places this provider in the 70th percentile of 255 psychiatric/mental health providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AristadaAripiprazole Lauroxil | 39 | $140,120 |
| Invega SustennaPaliperidone Palmitate | 29 | $96,723 |
| VraylarCariprazine Hcl | 48 | $77,689 |
| CaplytaLumateperone Tosylate | 30 | $43,852 |
| Modafinil | 12 | $6,429 |
| VyvanseLisdexamfetamine Dimesylate | 15 | $5,727 |
| Lisdexamfetamine Dimesylate | 17 | $4,294 |
| Aripiprazole | 96 | $3,722 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 50 | $2,937 |
| Quetiapine Fumarate | 105 | $2,661 |
| Paliperidone ErPaliperidone | 20 | $2,575 |
| Bupropion XlBupropion Hcl | 81 | $1,873 |
| Atomoxetine Hcl | 16 | $1,846 |
| Escitalopram Oxalate | 39 | $1,561 |
| Divalproex Sodium ErDivalproex Sodium | 50 | $1,511 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Alkermes, Inc.Aristada | $195 | $140,12039 claims |
| Johnson & JohnsonInvega Sustenna | $136 | $96,72329 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $572 | $43,85230 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 255 psychiatric/mental health providers in Nebraska.
Other psychiatric/mental health in Lincoln
- Helen TrotterLincoln$10K
- Marcia CarlsonLincoln$9K
- Trisha JobmanLincoln$9K
- Cory RabeLincoln$9K
- Kelley HanauLincoln$8K
- Tami OrtonLincoln$8K
- Michelle LemonLincoln$7K
- Serena MacauleyLincoln$7K
- Sabrina HellbuschLincoln$7K
- Rebecca OlanderLincoln$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.